TD Cowen Maintains Hold on Teladoc Health, Raises Price Target to $8
Wells Fargo Maintains Equal-Weight on Teladoc Health, Raises Price Target to $8
Barclays Maintains Equal-Weight on Teladoc Health, Raises Price Target to $9
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
TDOC Q3 deep dive: insurance-fueled BetterHelp pivot offsets cash pay headwinds, new care model launches
UBS Maintains Neutral on Teladoc Health, Raises Price Target to $9
Oppenheimer Maintains Outperform on Teladoc Health, Raises Price Target to $10
Teladoc’s Q3 earnings call: our top 5 analyst questions
JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10
Teladoc Health (TDOC) Stock Rebounds On Q3 Results As Cash Flow Improves
Teladoc Health, Inc. 2026 Q3 - Results - Earnings Call Presentation
Teladoc (TDOC) stock trades up, here is why
Teladoc Health, Inc. Q3 2026 Earnings Call Summary
Stifel Maintains Hold on Teladoc Health, Raises Price Target to $6.5
Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook
Needham Reiterates Hold on Teladoc Healthto Hold
Teladoc: 3 Key Takeaways for Long-Term Investors
Teladoc (TDOC) Q3 2026 Earnings Call Transcript
Teladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcript
Teladoc Health, Inc. Reports Third Quarter 2026 Revenue of $605.1 million
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.